Introduction to Sodium Bicarbonate 8.4% Injectable :- J-Bans ICU Care
Sodium Bicarbonate 8.4% Injectable is a critical care medication widely used in intensive care units (ICUs), emergency departments, and other medical settings to correct acid-base imbalances in the body. This hypertonic solution acts as an alkalizing agent, helping to neutralize excess acid in the blood and tissues. At J-Bans ICU Care, we offer this essential injectable under our trusted Soda Q brand, designed specifically for rapid intervention in life-threatening conditions. Our products are manufactured with the highest standards to ensure reliability during critical moments.
As a leading critical care PCD pharma company based in Delhi, India, J-Bans ICU Care provides Sodium Bicarbonate 8.4% Injectable solutions that are WHO-GMP and ISO certified, guaranteeing safety, efficacy, and consistency. Whether you’re a healthcare professional in Delhi or anywhere across Pan India, our Soda Q range is readily available through our extensive distribution network, ensuring timely access to high-quality ICU medications.
Top 10 Brands in India for Sodium Bicarbonate 8.4% Injectable
Here is a curated list of the top 10 brands for Sodium Bicarbonate 8.4% Injectable in India, focusing exclusively on Critical Care PCD pharma companies. This list excludes multinational corporations (MNCs) and highlights specialized Indian PCD entities known for their quality, distribution networks, and critical care focus. Rankings are based on market presence, product quality, and availability in the PCD pharma sector.
| Rank | Brand Name | Manufacturer | Key Features |
| 1 | Soda Q (Q 100, Q 25, Q 10) | J-Bans ICU Care | WHO-GMP & ISO certified; available in 100 mL, 25 mL, and 10 mL vials; Pan India distribution with monopoly franchise support; affordable pricing (e.g., Q 100 at ₹150); tailored for ICU use with high purity and sterility. |
| 2 | Sodac 8.4% | Neon Laboratories Ltd | Established PCD pharma player; sterile IV injection for metabolic acidosis; widely available in 100 mL vials; known for reliability in emergency care. |
| 3 | Auxisoda 8.4% | Alniche Life Sciences Pvt Ltd | PCD-focused company; treats acidosis and related conditions; part of a broad critical care portfolio; ensures quality through stringent manufacturing. |
| 4 | Sobimax 8.4% | Hospimax Healthcare Pvt Ltd | ISO-certified PCD entity; balances acid-alkaline levels; suitable for heartburn and acidosis; emphasizes safety and efficacy in formulations. |
| 5 | Intelico Sodium Bicarbonate 8.4% | Intelico Pharmaceuticals | Top-rated PCD pharma for injectables; high-quality production; focuses on critical care needs with competitive pricing and nationwide reach. |
| 6 | Sodarap 8.4% | Eurocrit Labs | PCD pharma manufacturer; 100 mL vial for neutralizing excess acid; 36-month shelf life; trusted for hospital and ICU supplies. |
| 7 | Sodabcot 8.4% | Scotmed Care Pvt. Ltd. | Leading PCD company; available in 25 mL packs; ISO 9001:2015 certified; offers third-party manufacturing and franchise opportunities. |
| 8 | Lexicare Sodium Bicarbonate 8.4% | Lexicare Pharma Pvt. Ltd. | Specialized PCD pharma; high-purity injection; part of a diverse product line; focuses on affordability and quality assurance. |
| 9 | Ambica Sodium Bicarbonate 8.4% | Ambica Pharma | PCD-oriented supplier; sterile solution for critical interventions; strong distribution in India; known for ethical practices. |
| 10 | Pharma Cure Sodium Bicarbonate 8.4% | Pharma Cure Laboratories | PCD pharma expert; vial-based injectable; emphasizes sterility and potency; available at competitive rates for bulk and franchise. |
Product Description
Sodium Bicarbonate 8.4% Injectable is a sterile, non-pyrogenic, hypertonic solution intended for intravenous (IV) administration. It is formulated as a systemic alkalizer and electrolyte replenisher, providing bicarbonate ions to combat metabolic acidosis. The 8.4% concentration equates to 84 mg/mL of sodium bicarbonate, delivering 1 mEq/mL each of sodium (Na+) and bicarbonate (HCO3-) ions. This makes it particularly potent for quick corrections in acid-base disturbances.
At J-Bans ICU Care, our Soda Q products are developed with a focus on emergency and ICU use, where precision and purity are paramount. The solution has a pH range of approximately 7.0 to 8.5, making it suitable for buffering in acute scenarios. It is free from preservatives and is supplied in single-dose vials to minimize contamination risks.
Key Features:
- Concentration: 8.4% w/v (84 mg/mL)
- Ionic Composition: Sodium 1 mEq/mL, Bicarbonate 1 mEq/mL
- Osmolarity: Approximately 2000 mOsm/L (hypertonic)
- Form: Clear, colorless aqueous solution
- Route of Administration: Intravenous only (injection or infusion)
Indications and Uses
Sodium Bicarbonate 8.4% Injectable is indicated for a variety of conditions where metabolic acidosis is present or imminent. It is a staple in critical care protocols and is used to:
- Correct Metabolic Acidosis: Associated with severe renal disease, uncontrolled diabetes (diabetic ketoacidosis), circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, and lactic acidosis.
- Cardiac Arrest Management: To treat acidosis during advanced cardiac life support (ACLS) protocols, particularly when blood gas analysis shows significant acidosis.
- Hyperkalemia Treatment: Helps shift potassium into cells by alkalizing the blood, reducing serum potassium levels in emergencies.
- Drug Overdose and Intoxications: Effective in managing overdoses of drugs like tricyclic antidepressants, barbiturates, salicylates (aspirin), and methanol/ethylene glycol poisoning, where it enhances urinary excretion or neutralizes toxicity.
- Urinary Alkalization: To increase urine pH and promote excretion of certain acidic drugs or to prevent renal tubular damage in conditions like rhabdomyolysis.
- Other Critical Care Scenarios: Including severe diarrhea leading to bicarbonate loss, hypochloremic states, and as an adjunct in sepsis or trauma-induced acidosis.
In ICU settings, it is often used in conjunction with blood gas monitoring to tailor therapy precisely. J-Bans’ Soda Q formulations ensure rapid onset of action, typically within minutes of IV administration.
Dosage and Administration
Dosage must be individualized based on the patient’s age, weight, clinical condition, and laboratory values (e.g., arterial blood gases, serum electrolytes). Always administer under medical supervision with continuous monitoring.
General Dosage Guidelines:
- Cardiac Arrest (Adults): Initial dose of 1 mEq/kg IV push (e.g., 50-100 mL of 8.4% solution for a 70 kg patient). Subsequent doses: 0.5 mEq/kg every 10 minutes, guided by blood pH and PaCO2.
- Metabolic Acidosis (Adults): Calculate base deficit using the formula: Dose (mEq) = 0.3 × body weight (kg) × base deficit (mEq/L). Administer half the calculated dose initially over 5-10 minutes, then reassess.
- Hyperkalemia (Adults): 50 mEq (50 mL) IV over 5 minutes, repeated as needed.
- Pediatric Dosing: 0.5-1 mEq/kg IV, diluted in appropriate fluids to avoid hypertonicity. For neonates: Use with caution, often diluted to 4.2%.
- Urinary Alkalization: 2-5 mEq/kg IV over 4-8 hours, adjusted to maintain urine pH >7.
Administration Instructions:
- Administer slowly via IV route to prevent complications like alkalosis or tissue damage. Rate: Not exceeding 1 mEq/kg/hour unless in emergencies.
- Dilute if necessary (e.g., with 5% dextrose or normal saline) for infusions.
- Compatible with most IV fluids but check for precipitation.
- Do not mix with calcium-containing solutions, as it may form insoluble precipitates.
- Use immediately after opening; discard unused portions.
Always base dosing on frequent blood gas and electrolyte monitoring to avoid over-correction.
Contraindications
Do not use Sodium Bicarbonate 8.4% Injectable in the following situations:
- Patients with metabolic or respiratory alkalosis.
- Patients losing chloride through vomiting, continuous gastrointestinal suction, or diuretics causing hypochloremic alkalosis.
- Hypocalcemia (risk of tetany).
- Hypokalemia (may worsen).
- Known hypersensitivity to sodium bicarbonate or any component.
- Congestive heart failure or renal insufficiency where sodium load is contraindicated.
- Conditions where alkalization could exacerbate issues, such as in certain respiratory failures.
Precautions and Warnings
- Monitoring: Regularly assess arterial blood gases, serum electrolytes (especially potassium, calcium, sodium), and fluid status to prevent alkalosis, hypernatremia, or hypokalemia.
- Rapid Administration Risks: Fast infusion can cause intravascular volume expansion, leading to pulmonary edema, especially in patients with heart or kidney impairment.
- Pregnancy and Lactation: Use only if clearly needed (Category C); monitor closely.
- Elderly Patients: Increased risk of fluid overload and electrolyte imbalances.
- Interactions: May inactivate catecholamines (e.g., norepinephrine) if mixed; enhances effects of certain drugs like quinidine.
- Extravasation: Can cause tissue necrosis; ensure secure IV access.
- Overdosage: Symptoms include alkalosis, hyperirritability, tetany. Treat by discontinuing and correcting electrolytes.
Handle with care in patients with edema, steroid use, or Addison’s disease.
Adverse Effects
Common side effects are related to over-correction or rapid administration:
- Metabolic: Alkalosis, hypernatremia, hypokalemia, hypocalcemia.
- Cardiovascular: Fluid overload, congestive heart failure exacerbation, pulmonary edema.
- Neurological: Irritability, tetany, muscle twitching, seizures.
- Local: Pain at injection site, phlebitis, extravasation injury.
- Other: Nausea, vomiting, abdominal pain, thirst.
Report severe reactions immediately. Incidence is low when used appropriately.
Storage and Handling
- Store at controlled room temperature below 25°C (77°F).
- Protect from light and freezing.
- Do not use if solution is discolored or contains particulates.
- Shelf life: Typically 24-36 months from manufacture; check expiration date.
- Handle aseptically; single-use vials only.
Packaging and Variants – J-Bans Soda Q Range
J-Bans ICU Care offers Sodium Bicarbonate 8.4% Injectable in convenient vial sizes under the Soda Q brand, tailored for different clinical needs:
- Soda Q 100: 100 mL vial – Ideal for larger doses in severe acidosis or cardiac arrest. Price: Approximately ₹150/vial. For a Detailed Product information Click Sodium Bicarbonate Injection 100 ml
- Soda Q 25: 25 mL vial – Suitable for moderate corrections or pediatric use. Price: Approximately ₹37.50/vial.
- Soda Q 10: 10 mL vial – Perfect for precise, smaller doses in emergencies or when minimal volume is required.
All variants are packaged in sterile glass vials with secure seals, ensuring integrity during transport and storage.
Why J-Bans ICU Care is the Best for Manufacturing and Distribution in Pan India
J-Bans ICU Care stands out as the premier choice for Sodium Bicarbonate 8.4% Injectable and other critical care Injections due to our unwavering commitment to quality, innovation, and accessibility.
Manufacturing Excellence
- State-of-the-Art Facilities: Our manufacturing units in Delhi adhere to WHO-GMP and ISO standards, ensuring every batch of Soda Q products meets international quality benchmarks. We use advanced protocols for sterility, purity, and potency testing.
- Research-Driven Approach: We continuously update formulations based on the latest medical research and global ICU standards, making our products reliable for high-stakes environments.
- Ethical Practices: As a dedicated critical care specialist, we focus on life-saving injectables without compromising on safety or efficacy.
Pan India Distribution Network
- PCD Pharma Franchise Model: We offer monopoly rights and full support to distributors across all states and union territories in India, enabling seamless Pan India coverage from Delhi to remote areas.
- Reliable Supply Chain: Timely deliveries through trusted wholesalers, suppliers, and logistics partners ensure no stockouts in ICUs or hospitals.
- Nationwide Reach: Connected with top cardiologists, pharma experts, and healthcare institutions, we provide customized solutions, technical guidance, and competitive pricing for long-term growth.
Why Choose J-Bans?
- Quality Assurance: WHO-GMP & ISO certified – every product, including Soda Q, undergoes rigorous testing for consistency.
- Customer-Centric Support: We prioritize the needs of doctors, hospitals, and distributors with 24/7 assistance, marketing materials, and training.
- Competitive Edge: Affordable pricing (e.g., Soda Q 100 at ₹151) combined with superior quality makes us the go-to for critical care needs.
- Proven Track Record: Trusted by ICUs nationwide for our portfolio covering antibiotics, electrolytes, anesthesia, and more.
- Sustainability and Ethics: Committed to ethical business, we foster strong partnerships for a robust critical care ecosystem in India.
For healthcare providers in Delhi or Pan India seeking dependable Sodium Bicarbonate solutions, J-Bans ICU Care delivers excellence every time.
Contact Us
- Location: 341, Vardhman Plaza, Vasundhara Enclave, Delhi-110096 , India
- Pan India Operations: Critical Care Injectable Franchise opportunities available nationwide
- Website: jbansicucare.com
- Email: info@jbansicucare.com
- Phone: +91 8527187932 (Contact for inquiries, orders, or franchise details)
“Trust J-Bans ICU Care for critical interventions – where quality saves lives.“